YCBD.PRA Stock Overview
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
cbdMD, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.69 |
| 52 Week High | US$3.50 |
| 52 Week Low | US$0.49 |
| Beta | 1.98 |
| 1 Month Change | -6.76% |
| 3 Month Change | 18.97% |
| 1 Year Change | -75.53% |
| 3 Year Change | -92.07% |
| 5 Year Change | n/a |
| Change since IPO | -92.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| YCBD.PRA | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -5.5% | 0.6% | 0.6% |
| 1Y | -75.5% | 13.1% | 25.7% |
Return vs Industry: YCBD.PRA underperformed the US Pharmaceuticals industry which returned 12.9% over the past year.
Return vs Market: YCBD.PRA underperformed the US Market which returned 25.7% over the past year.
Price Volatility
| YCBD.PRA volatility | |
|---|---|
| YCBD.PRA Average Weekly Movement | 13.5% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: YCBD.PRA has not had significant price volatility in the past 3 months.
Volatility Over Time: YCBD.PRA's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 52 | T. Kennedy | www.cbdmd.com |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.
cbdMD, Inc. Fundamentals Summary
| YCBD.PRA fundamental statistics | |
|---|---|
| Market cap | US$2.09m |
| Earnings (TTM) | -US$23.98m |
| Revenue (TTM) | US$23.45m |
0.1x
P/S Ratio-0.1x
P/E RatioIs YCBD.PRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YCBD.PRA income statement (TTM) | |
|---|---|
| Revenue | US$23.45m |
| Cost of Revenue | US$8.48m |
| Gross Profit | US$14.97m |
| Other Expenses | US$38.95m |
| Earnings | -US$23.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.88 |
| Gross Margin | 63.84% |
| Net Profit Margin | -102.28% |
| Debt/Equity Ratio | 0% |
How did YCBD.PRA perform over the long term?
See historical performance and comparison